Sarepta Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2012
Total Assets: $205.0M
Liabilities Breakdown FY2012
Total Liabilities: $81.3M
Asset Breakdown
Total Assets: $205.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $187.7M | 91.5% |
| Accounts Receivable | $4.7M | 2.3% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.4M | 1.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $4.9M | 2.4% |
| Other Assets | $4.3M | 2.1% |
Liabilities Breakdown
Total Liabilities: $81.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.5M | 9.3% |
| Long-Term Debt | $1.7M | 2.1% |
| Other Liabilities | $72.1M | 88.7% |